Novartis signs USD 2.1Billion for Endocyte acquisition Novartis has inked USD 2.1 billion agreement to takeover Endocyte. Endocyte, a biopharmaceutical company, headquartered in Indiana, licensed t...
FDA approves expanded label for Xarelto of Johnson & Johnson The Food and Drug Administration permitted labelling of blood thinner, Xarelto of Johnson & Johnson, as it can decrease the risk of major cardiovascular events in patients with peripheral artery disease or chronic coronary artery disease (CAD or P...
Find More
Gene Therapy is now touted as a new revolution for cancer treatment. If the list of new cancer treatment methodologies is traversed, then the end seems to be farther and farther away. As a sequel to the relentless efforts by researchers across the world to formulate therapies better than the existing ones, new prosp...
Find More
SNAPSHOTS: Copiktra receives FDA approval for CLL and FL, Relief for tazemetostat developers after FDA lifted partial clinical hold, Conference highlights from 19th WCLC The United States Food and Drug Administration (USFDA) has granted approval to Verastem’s Copiktra (duvelisib), for the treatment of patients with...
Find More
Orchard files for USD173 Million IPO to run pivotal gene therapy trials Orchard Therapeutics, Transatlantic biotech, has filed to raise USD 173 million in an IPO. This will lead it to take three gene therapies through the clinic. Orchard recognised itself as one of the broadest clinical-phase gene therapy pipelines ...
Find More
Laser Interstitial Thermal Therapy (LITT) is one of a hopeful treatment for brain cancer. Now, researchers are also using lasers to activate cancer-destroying drugs and other groups are testing the use of electrical fields to intersect the cancer cells division. The researchers are yet to determine the effectiveness...
Find More
DelveInsight's Infographic: Breast Cancer Precautions because October is the Breast Cancer Awareness Month. #breastcancer #cancer #infographic Apart from these precautions, women above 20 should start doing monthly self-breast examinations that can help in early detection of this disease. Hope that we can change...
Find More
Hologic complements Focal Therapeutics to its breast-conserving surgery for USD 125 Million Hologic, a global champion of women's health based in Massachusetts, United States, is taking possession of Focal Therapeutics, a medical device company, for USD 125 million to complement its breast-conserving surgery permit...
Find More
Companion diagnostics domain falls within the larger field of study called pharmacogenomics, which employs the person’s genomic makeup to predict a drug response or to tailor therapy specifically for that patient. The US FDA depicts companion diagnostics as an in vitro diagnostic device or an imaging tool, which pro...
Find More
A degenerative disease, Exocrine Pancreatic Insufficiency (EPI), is a consequence of insufficient pr.....
Find More
The medical device industry is experiencing rapid change as innovation is accelerating, new business.....
Find More
Soft Tissue Sarcoma (STS) tumors constitute 1% of all the malignancies. These are rare neoplasms tha.....
Find More
Neuroendocrine tumors (NET) are a rare kind neoplasm that arises from cells of the endocrine (hormon.....
Find More
Medical device manufacturing and development is a high-capital demanding endeavor and therefore the .....
Find More
Rheumatoid Arthritis (RA) is an inflammatory disorder that affects an individual's single or multipl.....
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
